Panagora Asset Management Inc Mirum Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$17.59 - $23.83 $945,673 - $1.28 Million	-53,762 Reduced 71.65%	21,270 $414,000
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $11,008 - $16,221	551 Added 0.74%	75,032 $1.58 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $92,007 - $137,362	4,995 Added 7.19%	74,481 $1.45 Million
Q1 2022 May 12, 2022	BUY	$15.5 - $23.93 $37,618 - $58,078	2,427 Added 3.62%	69,486 $1.53 Million
Q4 2021 Feb 10, 2022	BUY	$13.05 - $19.35 $508 - $754	39 Added 0.06%	67,059 $1.07 Million
Q3 2021 Nov 10, 2021	BUY	$13.95 - $20.18 $129,288 - $187,028	9,268 Added 16.05%	67,020 $1.34 Million
Q2 2021 Aug 11, 2021	SELL	$15.84 - $20.6 $2,233 - $2,904	-141 Reduced 0.24%	57,752 $999,000
Q1 2021 May 12, 2021	BUY	$16.29 - $21.92 $598,233 - $804,990	36,724 Added 173.48%	57,893 $1.15 Million
Q4 2020 Feb 10, 2021	BUY	$15.75 - $25.45 $333,411 - $538,751	21,169 New	21,169 $370,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.